Pharmafile Logo

OTC Awards

- PMLiVE

World Mental Health Day is on 10 October

You Okay, Doc? A call for more awareness and support for the mental health of doctors

The Real-Time Health System: Accelerating Workflows with Data

Bree Bush, Vice President, Chief Data Officer at GE Healthcare, dives into simulation modeling and advanced analytical tools to optimize inpatient, procedural, and clinic capacity; the concept of “real-time healthcare”;...

Impetus Digital

The Future of eHealth: Contactless Health Monitoring

Laurence Pearce, CEO & Founder of Xim Ltd, creators of Lifelight®, discusses the need for personal health monitoring; traditional issues associated with population health screening; AI, machine learning, and computer...

Impetus Digital

Two hands shaking symbolising partnership

Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly

In the first of this blog series, Patient Engagement Lead, Philippa Pristerà looks at making engagement processes more patient friendly

Cuttsy + Cuttsy

- PMLiVE

NICE recommends Novartis’ Adakveo for sickle cell disease

The treatment for sickle cell disease is the first in more than 20 years

- PMLiVE

Andy Black joins Lucid Group as non-executive chairman

Black is co-founder of Kinapse and a Professor of Practice at King’s College London

- PMLiVE

AstraZeneca requests Emergency Use Authorization from FDA for COVID-19 antibody

Phase 3 data shows the long-acting antibody combination produces a 77% reduction in the risk of developing symptomatic COVID-19

- PMLiVE

Christianna Gorin is appointed Health Practice Lead and Chief Strategy Officer, VMLY&R Health

With origins in health consultancy and insight, Gorin has spent over 20 years in healthcare

- PMLiVE

Fishawack Health appoints new CEO, Jonathan Koch

Koch will draw on his exceptional experience leading global, customer-centered organizations of scale to build a sustainable future for Fishawack Health.

Avalere Health

- PMLiVE

Janssen’s RSV vaccine provides high protection against respiratory infections

The phase 2b data showed the RSV vaccine provided 80% protection against lower respiratory infections in adults aged 65 and older

- PMLiVE

Black community representation in clinical trials

This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community.

Innovative Trials

ASHFIELD HEALTH LAUNCHES HEALTH INTELLIGENCE PLATFORM, GRAVITY.AI

Dynamic data-driven solution unlocks deeper insights and powers stronger omnichannel experiences.

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links